Halozyme Reports Second Quarter 2021 Results

Go back to Halozyme Reports Second Quarter 2021 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.62 --0 (-0%)
Previous Close $107.62    52 Week High $18.39 
Open $107.62    52 Week Low $6.96 
Day High $107.62    P/E N/A 
Day Low $107.62    EPS $-0.58 
Volume 297